Liqin Du

1.9k total citations
51 papers, 1.5k citations indexed

About

Liqin Du is a scholar working on Molecular Biology, Cancer Research and Neurology. According to data from OpenAlex, Liqin Du has authored 51 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 20 papers in Cancer Research and 14 papers in Neurology. Recurrent topics in Liqin Du's work include MicroRNA in disease regulation (16 papers), Neuroblastoma Research and Treatments (14 papers) and Cancer-related molecular mechanisms research (11 papers). Liqin Du is often cited by papers focused on MicroRNA in disease regulation (16 papers), Neuroblastoma Research and Treatments (14 papers) and Cancer-related molecular mechanisms research (11 papers). Liqin Du collaborates with scholars based in United States, Russia and China. Liqin Du's co-authors include Alexander Pertsemlidis, Zhenze Zhao, Yiqun Zhang, Philip A. Gregory, Gregory J. Goodall, Chad J. Creighton, Nishan Thilaganathan, Wei Lin, Zain H. Rizvi and Jonathan M. Kurie and has published in prestigious journals such as Genes & Development, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Liqin Du

47 papers receiving 1.5k citations

Peers

Countries citing papers authored by Liqin Du

Since Specialization

Citations

This map shows the geographic impact of Liqin Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liqin Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liqin Du more than expected).

Fields of papers citing papers by Liqin Du

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liqin Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liqin Du. The network helps show where Liqin Du may publish in the future.

Co-authorship network of co-authors of Liqin Du

This figure shows the co-authorship network connecting the top 25 collaborators of Liqin Du. A scholar is included among the top collaborators of Liqin Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liqin Du. Liqin Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	2-(3-Indolyl)acetamides and their oxazoline analogues: Anticancer SAR study 2024 ·Bioorganic & Medicinal Chemistry Letters ·Дмитрий А. Аксенов, (unknown), А. В. Аксенов, (unknown), Nicolai A. Aksenov, (unknown), (unknown), (unknown), (unknown), (unknown), Angela Zhang, Liqin Du, Alexander Kornienko	0
2	Systematic Analysis of miR-506-3p Target Genes Identified Key Mediators of Its Differentiation-Inducing Function 2024 ·Genes ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Emma Grace Lewis, (unknown), Liqin Du	1
3	Identification of CDKN3 as a Key Gene that Regulates Neuroblastoma Cell Differentiation 2024 ·Journal of Cancer ·(unknown), (unknown), (unknown), (unknown), (unknown), Emma Grace Lewis, Angela Zhang, Zhenze Zhao, Liqin Du	4
4	Development of Shortened miR-506-3p Mimics Exhibiting Strong Differentiation-Inducing Activity in Neuroblastoma Cells 2023 ·Molecules ·(unknown), Mitchell Smith, (unknown), Liqin Du	2
5	The Function and Regulation of SAPCD2 in Physiological and Oncogenic Processes 2022 ·Journal of Cancer ·(unknown), Liqin Du	1
6	[3 + 2]-Annulation of pyridinium ylides with 1-chloro-2-nitrostyrenes unveils a tubulin polymerization inhibitor 2021 ·Organic & Biomolecular Chemistry ·А. В. Аксенов, (unknown), (unknown), Дмитрий А. Аксенов, (unknown), Nicolai A. Aksenov, Huifen Wang, Liqin Du, Tania Betancourt, Stephen C. Pelly, Alexander Kornienko, Michael Rubin	20
7	Synthesis and biological evaluation of 10-benzyloxy-Narciclasine 2021 ·Tetrahedron ·(unknown), Zhenze Zhao, Liqin Du, Alexander Kornienko, Tomáš Hudlický	4
8	The PLAGL2/MYCN/miR-506-3p interplay regulates neuroblastoma cell fate and associates with neuroblastoma progression 2020 ·Journal of Experimental & Clinical Cancer Research ·Zhenze Zhao, Spencer D. Shelton, (unknown), (unknown), (unknown), (unknown), Liqin Du	19
9	ELF4 Is a Target of miR-124 and Promotes Neuroblastoma Proliferation and Undifferentiated State 2019 ·Molecular Cancer Research ·Adam Kosti, Liqin Du, Haridha Shivram, Qiao Mei, Suzanne S. Burns, (unknown), Alexander Pertsemlidis, Vishwanath R. Iyer, Erzsebet Kokovay, Luiz O. F. Penalva	15
10	microRNA-2110 functions as an onco-suppressor in neuroblastoma by directly targeting Tsukushi 2018 ·PLoS ONE ·Zhenze Zhao, (unknown), (unknown), Spencer D. Shelton, Cory Holland, Alexander Pertsemlidis, Liqin Du	26
11	miR-195 targets cyclin D3 and survivin to modulate the tumorigenesis of non-small cell lung cancer 2018 ·Cell Death and Disease ·Xiaojie Yu, Yiqiang Zhang, David Cavazos, Xiuye Ma, Zhenze Zhao, Liqin Du, Alexander Pertsemlidis	62
12	LMO1 functions as an oncogene by regulating TTK expression and correlates with neuroendocrine differentiation of lung cancer 2018 ·Oncotarget ·Liqin Du, Zhenze Zhao, Milind Suraokar, Spencer D. Shelton, Xiuye Ma, Tzu-Hung Hsiao, John D. Minna, Ignacio I. Wistuba, Alexander Pertsemlidis	12
13	microRNA-449a functions as a tumor suppressor in neuroblastoma through inducing cell differentiation and cell cycle arrest 2015 ·RNA Biology ·Zhenze Zhao, Xiuye Ma, Derek C. Sung, (unknown), Adam Kosti, (unknown), Yidong Chen, Alexander Pertsemlidis, Tzu-Hung Hsiao, Liqin Du	55
14	Genetic Mutation of p53 and Suppression of the miR-17∼92 Cluster Are Synthetic Lethal in Non–Small Cell Lung Cancer due to Upregulation of Vitamin D Signaling 2014 ·Cancer Research ·(unknown), Liqin Du, Zhenze Zhao, Elizabeth A. McMillan, Adam Kosti, Chin-Rang Yang, Milind Suraokar, Ignacio I. Wistuba, Adi F. Gazdar, John D. Minna, Michael A. White, Alexander Pertsemlidis	39
15	miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer 2013 ·Oncogene ·Liqin Du, Zengren Zhao, Xiuye Ma, (unknown), Pei‐Jer Chen, Emily Young, Milind Suraokar, Ignacio I. Wistuba, J D Minna, Alexander Pertsemlidis	69
16	miR-337-3p and Its Targets STAT3 and RAP1A Modulate Taxane Sensitivity in Non-Small Cell Lung Cancers 2012 ·PLoS ONE ·Liqin Du, M. Cecilia Subauste, Christopher DeSevo, Zhenze Zhao, (unknown), (unknown), Jeoffrey Schageman, (unknown), Chin-Rang Yang, Milind Suraokar, Ignacio I. Wistuba, Adi F. Gazdar, John D. Minna, Alexander Pertsemlidis	88
17	SR-A ligand and M-CSF dynamically regulate SR-A expression and function in primary macrophages via p38 MAPK activation 2011 ·BMC Immunology ·(unknown), (unknown), Liqin Du, Steven R. Post	21
18	Fem1b antigen in the stool of ApcMin mice as a biomarker of early Wnt signaling activation in intestinal neoplasia 2010 ·Cancer Epidemiology ·M. Cecilia Subauste, (unknown), Deyin Lu, Liqin Du, Owen J. Sansom, Joseph F. Maher	1
19	MicroRNA expression distinguishes SCLC from NSCLC lung tumor cells and suggests a possible pathological relationship between SCLCs and NSCLCs 2010 ·Journal of Experimental & Clinical Cancer Research ·Liqin Du, Jeoffrey Schageman, Irnov Irnov, Luc Girard, Scott M. Hammond, John D. Minna, Adi F. Gazdar, Alexander Pertsemlidis	56
20	Macrophage colony-stimulating factor differentially regulates low density lipoprotein and transferrin receptors 2004 ·Journal of Lipid Research ·Liqin Du, Steven R. Post	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact